论文信息 - Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)—Eudract number 2005–003911–63; NCT00311857 - 字舞流文

Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)—Eudract number 2005–003911–63; NCT00311857

J. Debus | K. Herfarth | W. Wick | C. Hartmann | A. Deimling | S. Combs | T. Welzel | L. Edler | M. Plattén | C. Timke | D. Schulz‐Ertner